Burning Rock Biotech Stock Fundamentals

BNR Stock  USD 6.16  0.85  16.01%   
Burning Rock Biotech fundamentals help investors to digest information that contributes to Burning Rock's financial success or failures. It also enables traders to predict the movement of Burning Stock. The fundamental analysis module provides a way to measure Burning Rock's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Burning Rock stock.
At this time, Burning Rock's Tax Provision is relatively stable compared to the past year. As of 12/01/2024, Net Interest Income is likely to grow to about 16 M, while Interest Expense is likely to drop 0.00.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Burning Rock Biotech Company Operating Margin Analysis

Burning Rock's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Burning Rock Operating Margin

    
  (0.82) %  
Most of Burning Rock's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Burning Rock Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Burning Pretax Profit Margin

Pretax Profit Margin

(1.27)

At this time, Burning Rock's Pretax Profit Margin is relatively stable compared to the past year.
Based on the recorded statements, Burning Rock Biotech has an Operating Margin of -0.8206%. This is 97.66% lower than that of the Biotechnology sector and 98.7% lower than that of the Health Care industry. The operating margin for all United States stocks is 85.11% lower than that of the firm.

Burning Rock Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Burning Rock's current stock value. Our valuation model uses many indicators to compare Burning Rock value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Burning Rock competition to find correlations between indicators driving Burning Rock's intrinsic value. More Info.
Burning Rock Biotech is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Burning Rock's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Burning Rock by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Burning Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Burning Rock's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Burning Rock could also be used in its relative valuation, which is a method of valuing Burning Rock by comparing valuation metrics of similar companies.
Burning Rock is currently under evaluation in operating margin category among its peers.

Burning Rock Current Valuation Drivers

We derive many important indicators used in calculating different scores of Burning Rock from analyzing Burning Rock's financial statements. These drivers represent accounts that assess Burning Rock's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Burning Rock's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap148.9B103.5B63.1B16.1B675.9M642.1M
Enterprise Value148.8B101.6B61.7B15.3B73.1M69.4M

Burning Rock ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Burning Rock's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Burning Rock's managers, analysts, and investors.
Environmental
Governance
Social

Burning Fundamentals

About Burning Rock Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Burning Rock Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Burning Rock using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Burning Rock Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue131.7 M112.2 M
Total Revenue537.4 M430.6 M
Cost Of Revenue174.2 M131.8 M
Stock Based Compensation To Revenue 0.49  0.25 
Sales General And Administrative To Revenue 0.81  0.56 
Research And Ddevelopement To Revenue 0.65  0.46 
Capex To Revenue 0.02  0.02 
Revenue Per Share 52.49  55.11 
Ebit Per Revenue(1.25)(1.31)

Pair Trading with Burning Rock

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.

Moving against Burning Stock

  0.65GANX Gain TherapeuticsPairCorr
  0.52BHC Bausch Health CompaniesPairCorr
  0.49HCM HUTCHMED DRCPairCorr
  0.42EWTX Edgewise TherapeuticsPairCorr
  0.41PFE Pfizer Inc Aggressive PushPairCorr
The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.
The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.